Inmaculada Hernandez, PharmD, PhD; Shivani Sampathkumar, BS; Chester B. Good, MD, MPH; Aaron S. Kesselheim, MD, JD, MPH; William H. Shrank, MD, MSHS
Acknowledgment: The authors thank Meiqi He for her help with the statistical analysis.
Financial Support: Dr. Kesselheim's work is funded by the Laura and John Arnold Foundation with additional support from the Harvard Program in Therapeutic Science and the Engelberg Foundation.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-1137.
Reproducible Research Statement:Study protocol and statistical code: Not available. Data set: The list of drugs included in the study is available from Dr. Hernandez (e-mail, firstname.lastname@example.org), but pricing data were obtained under data user agreements and licenses that do allow for reuse.
Hernandez I, Sampathkumar S, Good CB, et al. Changes in Drug Pricing After Drug Shortages in the United States. Ann Intern Med. 2019;170:74–76. [Epub ahead of print 18 September 2018]. doi: https://doi.org/10.7326/M18-1137
Download citation file:
Published: Ann Intern Med. 2019;170(1):74-76.
Published at www.annals.org on 18 September 2018
Healthcare Delivery and Policy.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use